Philips (NYSE:PHG) has issued corrections for some of its Trilogy Evo ventilator platforms due to multiple issues.

Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive ...

Philips has issued a voluntary recall of software for its Trilogy Evo ventilator series and a warning to patients not to use non-pneumatic nebulizers with the devices, as they may not deliver the ...

(Reuters) - Dutch medical device maker Philips said on Monday it has expanded an earlier recall of some respiratory machines to a total of 1,700 devices globally due to possible contamination of a ...

AMSTERDAM (Reuters) -Philips shares jumped 13% on Monday as the Dutch health technology company reported much better than expected first-quarter results and said it had set aside 575 million euros ...

The recall of a medical device is among the most serious actions a company can take in response to a safety issue or defect being associated with a device. In the US, the Food and Drug Administration ...